找回密碼
 To register

QQ登錄

只需一步，快速開始

掃一掃，訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Leading Pharmaceutical Innovation; How to Win the Life Oliver Gassmann,Alexander Schuhmacher,Gerrit Reepm Book 2018Latest edition Springer

[復(fù)制鏈接]
查看: 47353|回復(fù): 42
樓主
發(fā)表于 2025-3-21 18:14:06 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Leading Pharmaceutical Innovation
副標(biāo)題How to Win the Life
編輯Oliver Gassmann,Alexander Schuhmacher,Gerrit Reepm
視頻videohttp://file.papertrans.cn/583/582420/582420.mp4
概述Explores challenges for the pharmaceutical industry in times of competitive R&D and cost control pressure.Highlights three sources of innovation: new management methods; new technologies; new forms of
圖書封面Titlebook: Leading Pharmaceutical Innovation; How to Win the Life Oliver Gassmann,Alexander Schuhmacher,Gerrit Reepm Book 2018Latest edition Springer
描述.This book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management methods in the drug development pipeline; new technologies as enablers for cutting-edge R&D; and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. New models and methods are illustrated with cases from Europe, the US, and Asia. This third fully revised edition was expanded to reflect the latest updates in open and collaborative innovation, the greater strategic importance of venture capital and early-stage investments, and the new range of emerging technologies now being put to use in pharmaceutical innovation..
出版日期Book 2018Latest edition
關(guān)鍵詞Pharmaceutical industry; Pharmaceuticals; Pharmacoeconomics; Drug discovery; Innovation; R&D; Innovation m
版次3
doihttps://doi.org/10.1007/978-3-319-66833-8
isbn_softcover978-3-030-09782-0
isbn_ebook978-3-319-66833-8
copyrightSpringer International Publishing AG, part of Springer Nature 2018
The information of publication is updating

書目名稱Leading Pharmaceutical Innovation影響因子(影響力)




書目名稱Leading Pharmaceutical Innovation影響因子(影響力)學(xué)科排名




書目名稱Leading Pharmaceutical Innovation網(wǎng)絡(luò)公開度




書目名稱Leading Pharmaceutical Innovation網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Leading Pharmaceutical Innovation被引頻次




書目名稱Leading Pharmaceutical Innovation被引頻次學(xué)科排名




書目名稱Leading Pharmaceutical Innovation年度引用




書目名稱Leading Pharmaceutical Innovation年度引用學(xué)科排名




書目名稱Leading Pharmaceutical Innovation讀者反饋




書目名稱Leading Pharmaceutical Innovation讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics
 

0票 0%

Better Implies Difficulty
 

0票 0%

Good and Satisfactory
 

0票 0%

Adverse Performance
 

0票 0%

Disdainful Garbage
您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 20:47:59 | 只看該作者
板凳
發(fā)表于 2025-3-22 00:40:54 | 只看該作者
地板
發(fā)表于 2025-3-22 08:39:22 | 只看該作者
5#
發(fā)表于 2025-3-22 12:14:13 | 只看該作者
Oliver Gassmann,Alexander Schuhmacher,Max von Zedtwitz,Gerrit Reepmeyerent of immune disease by conditioning procedures (Ader, 1981). About twenty years ago the British immunologist John Humphreys published a study with others showing that the local inflammation and swelling that follows injection of an extract of tubercle bacilli into the skin (the tuberculin reaction
6#
發(fā)表于 2025-3-22 14:59:50 | 只看該作者
7#
發(fā)表于 2025-3-22 17:51:22 | 只看該作者
8#
發(fā)表于 2025-3-22 22:24:42 | 只看該作者
Oliver Gassmann,Alexander Schuhmacher,Max von Zedtwitz,Gerrit Reepmeyersol, but the prospect of surgery can be just as effective, as can admission to hospital, the prospect of a college or university examination, or the expectation of exhausting physical exercise. On the one hand the physiological response to stress, as after injury, is of greatest concern, while on th
9#
發(fā)表于 2025-3-23 02:12:25 | 只看該作者
10#
發(fā)表于 2025-3-23 06:29:06 | 只看該作者
the greater strategic importance of venture capital and early-stage investments, and the new range of emerging technologies now being put to use in pharmaceutical innovation..978-3-030-09782-0978-3-319-66833-8
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 18:19
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
仙桃市| 米林县| 古丈县| 潼南县| 威海市| 会同县| 永兴县| 桓仁| 望江县| 海门市| 衡东县| 中山市| 新营市| 原平市| 固镇县| 镇安县| 澳门| 抚州市| 龙门县| 治县。| 荣成市| 东丰县| 太谷县| 桐柏县| 叶城县| 慈利县| 呼玛县| 陇南市| 雅江县| 三门县| 澎湖县| 建阳市| 永昌县| 昆山市| 长沙市| 英吉沙县| 威海市| 沾益县| 外汇| 平度市| 东乡族自治县|